4th Quarter - Report

GOLDBUG STRATEGIES LLC for GENOMIC HEALTH INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

FDA regulation of laboratory developed tests, in vitro diagnostic products. 21st Century Cures Initiative, Medicare reimbursement for laboratory developed tests and in vitro diagnostic products.

LobbyistCovered position, as disclosed
SHEILA D WALCOFF 2006-07 Counselor to HHS Secretary Michael O. Leavitt (Immed

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

FDA regulation of laboratory developed tests, in vitro diagnostic products. 21st Century Cures Initiative, Medicare reimbursement for laboratory developed tests and in vitro diagnostic products.

LobbyistCovered position, as disclosed
SHEILA D WALCOFF 2006-07 Counselor to HHS Secretary Michael O. Leavitt (Immed

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Medicare reimbursement for laboratory developed tests and in vitro diagnostic products.

LobbyistCovered position, as disclosed
SHEILA D WALCOFF 2006-07 Counselor to HHS Secretary Michael O. Leavitt (Immed

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.